We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$290K
Cap. Flow
-$14M
Cap. Flow %
-5.35%
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30

Sector Composition

Rank Sector Weight
1 Materials 30.32%
2 Healthcare 27.8%
3 Miscellaneous 13.82%
4 Financials 10.28%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLMT icon
1
Calumet Specialty Products
CLMT
$4.2B
$77.3M 29.54%
4,325,000
-251,000
-5% -$4.07M
APO icon
2
Apollo Global Management
APO
$79.7B
$21M 8.01%
225,000
FTAI icon
3
FTAI Aviation
FTAI
$20B
$19.7M 7.54%
425,000
CLOZ icon
4
Panagram BBB-B CLO ETF
CLOZ
$803M
$19M 7.26%
719,368
+598,336
+494% +$15.7M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.19T
$15.8M 6.04%
112,220
DCGO icon
6
DocGo
DCGO
$39.3M
$10.8M 4.11%
1,925,000
ARDX icon
7
Ardelyx
ARDX
$984M
$8.56M 3.27%
1,380,000
-120,000
-8% -$538K
LGND icon
8
Ligand Pharmaceuticals
LGND
$5.59B
$8.21M 3.14%
115,000
ICLO icon
9
Invesco AAA CLO Floating Rate Note ETF
ICLO
$550M
$7.85M 3%
307,019
+229,642
+297% +$5.87M
OABI icon
10
OmniAb
OABI
$650M
$6.7M 2.56%
1,086,505
VKTX icon
11
Viking Therapeutics
VKTX
$3.75B
$5.04M 1.93%
270,822
+85,267
+46% +$1.12M
JAAA icon
12
Janus Henderson AAA CLO ETF
JAAA
$30B
$4.71M 1.8%
93,647
+62,215
+198% +$3.12M
JPM icon
13
JPMorgan Chase
JPM
$951B
$3.57M 1.36%
20,985
AVDL
14
DELISTED
Avadel Pharmaceuticals
AVDL
$3.56M 1.36%
251,850
+30,000
+14% +$352K
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$12.3B
$3.42M 1.31%
14,800
-200
-1% -$35K
PFE icon
16
Pfizer
PFE
$159B
$2.81M 1.07%
97,537
CSX icon
17
CSX Corp
CSX
$95B
$2.43M 0.93%
70,000
GSK icon
18
GSK
GSK
$102B
$2.41M 0.92%
65,000
INZY
19
DELISTED
Inozyme Pharma
INZY
$2.4M 0.92%
564,549
+110,541
+24% +$393K
CLOX icon
20
Panagram AAA CLO ETF
CLOX
$323M
$2.35M 0.9%
92,956
+77,316
+494% +$1.96M
SNY icon
21
Sanofi
SNY
$107B
$2.34M 0.89%
+47,000
New +$2.3M
CPRX
22
DELISTED
Catalyst Pharmaceutical
CPRX
$2.11M 0.81%
+125,450
New +$1.71M
TVTX icon
23
Travere Therapeutics
TVTX
$6.19B
$1.99M 0.76%
221,005
+120,688
+120% +$879K
CHRS icon
24
Coherus Oncology
CHRS
$218M
$1.75M 0.67%
526,312
-103,688
-16% -$278K
CVE icon
25
Cenovus Energy
CVE
$58.2B
$1.58M 0.6%
95,000

Similar funds

David M. Knott Jr's Q4 2023 Portfolio in Review

As of Q4 2023, David M. Knott Jr held 143 positions worth $262M, down 0.11% from $262M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

David M. Knott Jr withdrew a net $14M in Q4 2023, closing 30 positions and reducing 10 holdings. Its most notable exit was Midwest Holding Inc. Common Stock, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $2.34M.

  • David M. Knott Jr's largest Q4 2023 buy was Sanofi: 47,000 shares worth $2.34M.
  • David M. Knott Jr added most to Panagram BBB-B CLO ETF in Q4 2023, an estimated $15.7M increase.
  • David M. Knott Jr's biggest Q4 2023 reduction was Calumet Specialty Products, cutting an estimated $4.07M.
  • David M. Knott Jr fully exited Midwest Holding Inc. Common Stock in Q4 2023, selling an estimated $10.2M.
  • David M. Knott Jr's ten largest holdings make up 74% of its $262M portfolio in Q4 2023.
  • David M. Knott Jr opened 12 new positions and closed 30 in Q4 2023.
  • David M. Knott Jr's portfolio value fell 0.11% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.